MedWatch

Novo-VP dreams of subsidiaries in 90 countries

Novo Nordisks Head of International Operations talks to Medwatch about the focus of the company when entering new markets and reveals which countries could be next in line as growth markets for the diabetes giant.

“I just came back from Buenos Aires this Sunday, I was in Switzerland yesterday, and today I am here in bagsværd, and I will head back to Switzerland tomorrow, only to continue to Nigeria next week.”

Jesper Høiland is Senior Vice President of International Operations (IO) in Novo Nordisk and is thus responsible for a total of 153 countries, which is evident as he talks about his extensive travel itinerary, when Medwatch meets him for an interview at Novo’s headquarters in Bagsværd.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Eli Lilly får forlomme til fedmehåb hos FDA

Med en fast track status får medicinalselskabet Eli Lilly sænket behandlingstiden for sin registreringsansøgning hos FDA af lægemiddelhåbet Tirzepatid til omtrent seks måneder fra de normale ca. 10 måneder.

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier